News
A blood test measuring changes in CA-125 concentrations is highly effective in detecting ovarian cancer, according to results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 46 237 women, aged 50 years and older, assigned to the multimodal screening (MMS) group of the trial had blood levels of CA-125 tested every year from 2002–11. An algorithm was then used to estimate every woman’s risk of ovarian cancer, referring them to specialists accordingly. During the course of 296 911 women-years of incidence screening,640(
A blood test measuring changes in CA-125 concentrations is highly effective in detecting ovarian cancer, according to results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). 46 237 women, aged 50 years and older, assigned to the multimodal screening (MMS) group of the trial had blood levels of CA-125 tested every year from 2002–11. An algorithm was then used to estimate every woman’s risk of ovarian cancer, referring them to specialists accordingly. During the course of 296 911 women-years of incidence screening,640(
